Updated Jul 16, 2026
Catinazzo Thomas has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $4.81M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-08 | RLAY | Relay Therapeutics, Inc. | S — Open-market sale | 17.7K | $18.69 | $331K |
| 2026-06-24 | RLAY | Relay Therapeutics, Inc. | S — Open-market sale | 51.6K | $16.97 | $875K |
| 2026-06-24 | RLAY | Relay Therapeutics, Inc. | M — Option exercise | 51.6K | $4.45 | $229K |
| 2026-06-24 | RLAY | Relay Therapeutics, Inc. | S — Open-market sale | 61.6K | $16.97 | $1.04M |
| 2026-06-24 | RLAY | Relay Therapeutics, Inc. | M — Option exercise | 61.6K | $5.22 | $321K |
| 2026-06-24 | RLAY | Relay Therapeutics, Inc. | S — Open-market sale | 56.3K | $16.97 | $956K |
| 2026-06-24 | RLAY | Relay Therapeutics, Inc. | M — Option exercise | 56.3K | $5.04 | $284K |
| 2026-06-24 | RLAY | Relay Therapeutics, Inc. | S — Open-market sale | 17.7K | $17.01 | $301K |
| 2026-05-14 | RLAY | Relay Therapeutics, Inc. | S — Open-market sale | 17.7K | $12.86 | $228K |
| 2026-04-10 | RLAY | Relay Therapeutics, Inc. | S — Open-market sale [10b5-1] | 1.8K | $15.00 | $27K |
| 2026-04-10 | RLAY | Relay Therapeutics, Inc. | M — Option exercise [10b5-1] | 1.8K | $5.22 | $9K |
| 2026-04-10 | RLAY | Relay Therapeutics, Inc. | S — Open-market sale [10b5-1] | 17.7K | $13.01 | $230K |
| 2026-03-11 | RLAY | Relay Therapeutics, Inc. | S — Open-market sale [10b5-1] | 17.7K | $10.06 | $178K |
| 2026-01-29 | RLAY | Relay Therapeutics, Inc. | S — Open-market sale | 1.7K | $8.45 | $14K |
| 2026-01-29 | RLAY | Relay Therapeutics, Inc. | S — Open-market sale | 13.8K | $7.62 | $105K |
| 2025-10-30 | RLAY | Relay Therapeutics, Inc. | S — Open-market sale | 21.7K | $7.29 | $158K |
| 2025-10-30 | RLAY | Relay Therapeutics, Inc. | S — Open-market sale | 21.7K | $7.29 | $158K |
| 2025-07-28 | RLAY | Relay Therapeutics, Inc. | S — Open-market sale | 18.4K | $3.68 | $68K |
| 2025-07-28 | RLAY | Relay Therapeutics, Inc. | S — Open-market sale | 1.7K | $3.74 | $6K |
| 2024-12-31 | RLAY | Relay Therapeutics, Inc. | S — Open-market sale [10b5-1] | 4.6K | $4.42 | $20K |
Catinazzo Thomas is a corporate insider — currently tracked as Insider of Relay Therapeutics, Inc. (RLAY). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 22 open-market sales ($4.81M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Catinazzo Thomas profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.